ECONOMIC IMPACT OF LONG VERSUS SHORT PERIPHERAL VENOUS CATHETERS: A BUDGET IMPACT ANALYSIS IN HOSPITALIZED PATIENTS
Author(s)
Lucas Grozewicz Scultori, Pharmacist1, CRISTINA N. FERREIRA, MBA, MSc, PharmD2, LAIS MARQUES PIMENTA, Pharmacist3, CARLOS DAMASCENO, Nurse1.
1Laboratórios B.Braun, Rio de Janeiro, Brazil, 2Market Access leader, Laboratórios B.Braun, Rio de Janeiro, Brazil, 3Universidade Federal Fluminense, Rio de Janeiro, Brazil.
1Laboratórios B.Braun, Rio de Janeiro, Brazil, 2Market Access leader, Laboratórios B.Braun, Rio de Janeiro, Brazil, 3Universidade Federal Fluminense, Rio de Janeiro, Brazil.
OBJECTIVES: To evaluate the economic outcome and budget impact of replacing short peripheral intravenous catheters (PIVCs) with long peripheral venous catheters in hospitalized patients, aiming to reduce high complication rates, frequent replacements, and the total cost of care.
METHODS: A budget impact analysis was conducted from the perspective of hospital managers in public and private hospitals. The model simulated a cohort of 1,000 patients with an average 8-day hospital stay, where 800 patients required peripheral access and 53.7% (430 patients) were projected to experience short catheter failure within 48 hours. Microcosting included catheters, extension sets, dressings, pre-filled syringes, connectors, and gauze. The short PIVC baseline cost was BRL 23.76 per insertion, requiring sequential replacements every 48 hours (BRL 95.04 per course), while the long PIVC intervention cost was BRL 38.26, maintaining patency without replacements throughout the 8-day period.
RESULTS: The total treatment cost for the cohort using short PIVCs was BRL 40,829.18, compared to BRL 16,436.50 when adopting long PIVCs. Transitioning to long peripheral catheters generated a total savings of BRL 24,392.69, which represents a 59.74% reduction in direct supply expenditures.
CONCLUSIONS: Adopting technology that lowers failure rates drastically reduces clinical maintenance costs and optimizes hospital budget allocation. The transition to long peripheral venous catheters proves to be a highly strategic decision for supply chain optimization, cost reduction, and clinical efficiency.
METHODS: A budget impact analysis was conducted from the perspective of hospital managers in public and private hospitals. The model simulated a cohort of 1,000 patients with an average 8-day hospital stay, where 800 patients required peripheral access and 53.7% (430 patients) were projected to experience short catheter failure within 48 hours. Microcosting included catheters, extension sets, dressings, pre-filled syringes, connectors, and gauze. The short PIVC baseline cost was BRL 23.76 per insertion, requiring sequential replacements every 48 hours (BRL 95.04 per course), while the long PIVC intervention cost was BRL 38.26, maintaining patency without replacements throughout the 8-day period.
RESULTS: The total treatment cost for the cohort using short PIVCs was BRL 40,829.18, compared to BRL 16,436.50 when adopting long PIVCs. Transitioning to long peripheral catheters generated a total savings of BRL 24,392.69, which represents a 59.74% reduction in direct supply expenditures.
CONCLUSIONS: Adopting technology that lowers failure rates drastically reduces clinical maintenance costs and optimizes hospital budget allocation. The transition to long peripheral venous catheters proves to be a highly strategic decision for supply chain optimization, cost reduction, and clinical efficiency.
Conference/Value in Health Info
2026-11, ISPOR Europe 2026, Vienna, Austria
Value in Health, Volume 29, Issue 12S
Code
EE126
Topic
Economic Evaluation
Topic Subcategory
Budget Impact Analysis
Disease
Injury & Trauma, Systemic Disorders/Conditions (Anesthesia, Auto-Immune Disorders (n.e.c.), Hematological Disorders (non-oncologic), Pain)